Calculated based on number of publications stored in Pure and citations from Scopus
20002022

Research activity per year

If you made any changes in Pure these will be visible here soon.
Filter
Review article

Search results

  • 2011

    Crizotinib. ALK/Met inhibitor, oncolytic

    Nwizu, T., Kanteti, R., Kawada, I., Rolle, C., Vokes, E. E. & Salgia, R., 2011 Feb, In: Drugs of the Future. 36, 2, p. 91-98 8 p.

    Research output: Contribution to journalReview articlepeer-review

    11 Citations (Scopus)